Lupin launches blood sugar control injection in US
Mumbai-based pharma company Lupin Ltd has launched Liraglutide injection to help control blood sugar in the United States. The injection, available in an 18 mg/3 mL single-patient prefilled pen, is used along…
Weight loss drug ‘Ozempic’ approved for use in India: What we need to know about its health benefits and risks
India has officially approved the use of Ozempic (semaglutide), a once-a-week injection designed for adults with type 2 diabetes. Approved by the Central Drugs Standard Control Organisation (CDSCO), this drug…
Eye stroke alert: Ozempic linked to rare vision-loss condition
If you’re on Ozempic or Wegovy to manage type 2 diabetes—or to shed some pounds—there’s something new you should have on your radar. Doctors are now flagging a rare but…
Diabetes drug shows promise for treating prostate cancer
An international team of scientists led by the Medical University of Vienna has identified similarities in the mechanisms of diabetes and cancer: as the researchers show, the protein PPARγ, which…
FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes
The FDA today approved the first generic referencing the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide (Victoza), an 18 mg/3 mL injection, to improve glycemic control in patients aged 10 years and older…
